1. 27LBA Evidence of activity of a new mechanism of action (MoA): A first-in-human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640, as monotherapy or in combination. Issue 3 (September 2015) Authors: Arkenau, H.T.; Voskoboynik, M.; Infante, J.; Brenner, A.; Patel, M.; Borazanci, E.; Falchook, G.; Molife, L.R.; Pant, S.; Dean, E.; Pelosof, L.; Jones, S.; Rubino, C.; McCulloch, W.; Zhukova-Harrill, V.; Kemble, G.; O'Farrell, M.; Burris, H. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy signals, long-term exposure and safety data from a phase 1–2 study of a cell-penetrating peptide antagonist of CEBPβ, a novel target, in patients (pts) with refractory solid tumors. (October 2022) Authors: Fontana, E.; Williams, A.; Falchook, G.; Lakhani, N.; Evans, T.R.J.; Gondi, V.; Iwamoto, F.; McKean, M.; Symeonides, S.; Butowski, N.; McLaren, A.; Henry, J.; Buerki, R.; Rotolo, J.; Capiaux, G.; Michel, R.; Kaesshaefer, S.; Wiegert, E.; Bexon, A. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P0110 Safety and anti-tumour activity of pegylated recombinant human IL-10 (AM0010) in selected advanced solid tumours. (July 2015) Authors: Naing, A; Infante, J.R.; Papadopoulos, K.P.; Autio, K.A.; Ott, P.A.; Falchook, G.; Wong, D.; Whiteside, M.; Oft, M. Journal: European journal of cancer Issue: Volume 51(2015)Supplement 2 Page Start: e22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Preliminary results from HERKULES-1: a phase 1b/2, open-label, multicenter study of ERAS-007, an oral ERK1/2 inhibitor, in patients with advanced or metastatic solid tumors. (October 2022) Authors: Wang, J.; Johnson, M.; Barve, M.; Pelster, M.; Chen, X.; Li, Z.; Gordon, J.; Reiss, M.; Pai, S.; Falchook, G.; Tolcher, A. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response. Issue 1 (December 2015) Authors: Liu, X.; George, G.; Tsimberidou, A.; Naing, A.; Wheler, J.; Kopetz, S.; Fu, S.; Piha-Paul, S.; Eng, C.; Falchook, G.; Janku, F.; Garrett, C.; Karp, D.; Kurzrock, R.; Zinner, R.; Raghav, K.; Subbiah, V.; Hess, K.; Meric-Bernstam, F.; Hong, D. Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗